ArticleScientific reports2025
An intelligent hybrid grey wolf-particle swarm optimizer for optimization in complex engineering design problem.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Adaptive Reinforced Gray Langur Optimization for Feature Selection and SVR Modeling of Polysaccharides inBiomimetics (Basel, Switzerland) · 2026Article
- Article
- Hybrid PSO-GWO optimization for converter-free grid integration of parallel induction generators with experimental validation in micro-hydro power plants.Scientific reports · 2026Article
- Optimal design and operation of grid-connected hybrid microgrid system using pelican optimization algorithm.Scientific reports · 2026Article
- Improved one-dimensional residual network high-voltage DC diagnosis for high-precision fault identification.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Engineering design optimization problems present significant challenges due to the complexity of objective functions, which often involve both continuous and discrete design variables, along with multiple constraints. GWO and PSO are well-known heuristic algorithms with efficient search ability and reasonable execution time. They are often used to solve complex optimization problems, but there are still problems such as premature convergence and limited global search efficiency. To overcome these limitations and enhance solution quality, this study proposes a novel Hybrid Grey Wolf-Particle Swarm Optimization (HGWPSO) algorithm. HGWPSO integrates the exploration ability of GWO with the rapid convergence and exploitation efficiency of PSO. The algorithm's performance is first validated using CEC_2022 benchmark functions and then applied to eight complex engineering design problems, including pressure vessel design, compression spring design, three-bar truss design, gear train design, cantilever beam design, welded beam design, transmission line parameter estimation, and reactive power planning problem. The improvement in the average best optimal value varies across different cases, demonstrating the effectiveness of the proposed method. In Case 1, the improvement is 71.61%, while in Cases 2 and 4 obtained a 99% improvement. Case 3 shows an enhancement of 53.46%, and Case 5 reaches 71.92%, whereas Case 6 also obtained 99%. In Case 7, the improvement depends on the bundle configuration, with two-bundle conductors showing a 76.91% increase, three-bundle conductors achieving 43.94%, and four-bundle conductors reaching 46.57%. Finally, in Case 8, the improvement is 1.02%. The obtained results demonstrate that HGWPSO achieves better performance than other methods in terms of convergence rate, cost function minimization, and constraint handling. This study highlights the effectiveness of HGWPSO as a powerful tool for solving complex engineering design problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.